Clinical Trial: A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807865) titled 'A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)' on Sept. 02.

Brief Summary: The purpose of this study is to assess how safe ITI-1284 is and how well it can be tolerated in long-term, when given alone or with other medicines, in participants with generalized anxiety disorder (GAD) who have not responded to treatment previously. GAD is a mental health condition defined by constant, uncontrollable worry about everyday things that lasts for six months or more.

Study Start Date: Sept. 03

Study Type: INTERVENTIONAL

Condition: Genera...